vendredi 14 octobre 2016

Onco Actu du 14 octobre 2016

1. Biologie

Genomic causation....or not [The Mermaid's Tale]

Faulty molecule offers new target for treating liver cancer [The Institute of Cancer Research]

2. Etiologie

Common prostate cancer treatment linked to later dementia, researcher says [Stanford Medicine]

Hormone therapy for prostate cancer associated with greater risk of dementia [STAT]

Prostate cancer treatment could double the chance of dementia [The Telegraph]

Prostate Cancer Treatment Can Raise Dementia Risk [NY Times]

2.7 Etiologie - Obésité

Obesity and Diabetes Tied to Liver Cancer [NY Times]

4.2 Dép., diag. & prono. - Génome

Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer [HealthNewsReview]

4.9 Dép., diag. & prono. - Sein

The Case Against The Case Against Mammography [Forbes]

A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month [Respectful Insolence]

5. Traitements

Kantar Health Launches New Oncology Platform, Allowing Healthcare Companies to Better Understand Drug Opportunities [Kantar Health]

5.10 Traitements - Essais

10-Year Follow-up in the ProtecT Trial [Now@NEJM]

5.12 Immunothérapies

With 20 Agents, 803 Trials, and 166,736 Patient Slots, Is Pharma Investing Too Heavily in PD-1 Drug Development? [The Cancer Letter]

Denmark's Genmab looks to immunotherapy for cancer drug encore [Reuters]

5.12.2 Immunothérapies - CAR-T

WuXi opens CAR-T biomanufacturing facility in Philadelphia [FierceBiotech]

5.2 Pharma

OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer [OncoGenex]

TG Therapeutics maps a shortcut to the FDA with lead drug for CLL [EndPoints]

Tesaro v Myriad: Niraparib partners squared off in court as Tesaro tried to quash a contrary press release [Endpoints]

5.3 Traitements - FDA, EMA, NICE...

First comprehensive overview of global initiatives on medicine regulation published [EMA]

Patients to get faster access to the most cost effective treatments under proposed changes to NICE's process [NICE]

6.1 Observation

Breast Cancer Death Rates Are Down, But Racial Disparities Persist [NPR]

Cancer waiting times: what’s causing the delays? [Cancer Research UK]

U.S. breast cancer deaths drop; rate among white women falls most [Reuters]

6.10.1 Politiques (USA)

NIH funds additional medical centers to expand national precision medicine research program [NIH]

6.11 Patients

Cemetery walks and playwriting: How I found healing after breast cancer [STAT]

Living With Cancer: Lessons on Dying From David Bowie and My Friends [NY Times]

6.6 Publications

Cancer researcher earns 5th retraction after misconduct finding [Retraction Watch]